R.J. Reynolds Tobacco Makes Significant Step on Tobacco Harm Reduction; FDA to Continue its Evaluation on Modified-Risk Claims for Camel Snus
WINSTON-SALEM, N.C. – Sept. 14, 2018 – Today, a scientific advisory committee of the U.S. Food and Drug Administration (FDA) advanced R.J. Reynolds Tobacco Company’s (R.J. Reynolds) efforts to communicate reduced-risk information to consumers regarding its Camel Snus products. The Tobacco Products Scientific Advisory Committee (TPSAC) recognized that the available science supports that switching completely from cigarettes … Continued